Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
1-Year Return
23.83%
This Quarter Return
+11.3%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$52.3B
AUM Growth
+$4.34B
(+9%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79
Top Buys
| 1 |
Tesla
TSLA
|
+$125M |
| 2 |
Home Depot
HD
|
+$110M |
| 3 |
Verizon
VZ
|
+$109M |
| 4 |
IS
ironSource Ltd.
IS
|
+$107M |
| 5 |
Pfizer
PFE
|
+$105M |
Top Sells
| 1 |
AT&T
T
|
+$246M |
| 2 |
Intel
INTC
|
+$218M |
| 3 |
Ford
F
|
+$164M |
| 4 |
Micron Technology
MU
|
+$149M |
| 5 |
General Motors
GM
|
+$144M |
Sector Composition
| 1 | Technology | 25.17% |
| 2 | Healthcare | 14.97% |
| 3 | Financials | 14.2% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RIDE
1676
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $424K | ﹤0.01% |
+8,199
| New | +$424K |
|
1677
eXp World Holdings
EXPI
$1.76B
| $423K | ﹤0.01% |
+12,570
| New | +$423K |
|
1678
First Bancorp
FBNC
$2.27B
| $422K | ﹤0.01% |
9,220
-4,180
| -31% | -$191K |
|
1679
Warrior Met Coal
HCC
$3.08B
| $420K | ﹤0.01% |
16,350
-3,350
| -17% | -$86.1K |
|
1680
SpartanNash
SPTN
$900M
| $420K | ﹤0.01% |
16,315
-35,070
| -68% | -$903K |
|
|
DEA
1681
Easterly Government Properties
DEA
$1.06B
| $419K | ﹤0.01% |
7,316
-36,124
| -83% | -$2.07M |
|
1682
Dynavax Technologies
DVAX
$1.14B
| $419K | ﹤0.01% |
+29,750
| New | +$419K |
|
|
LTC
1683
LTC Properties
LTC
$1.68B
| $418K | ﹤0.01% |
12,234
-30,430
| -71% | -$1.04M |
|
1684
Quince Therapeutics
QNCX
$86.5M
| $417K | ﹤0.01% |
+33,040
| New | +$417K |
|
|
QVCGA
1685
QVC Group, Inc. Series A Common Stock
QVCGA
$83.7M
| $417K | ﹤0.01% |
1,099
+66
| +6% | +$25K |
|
|
WW
1686
DELISTED
WW International
WW
| $416K | ﹤0.01% |
25,800
-27,300
| -51% | -$440K |
|
1687
Rivian
RIVN
$16.9B
| $415K | ﹤0.01% |
+4,005
| New | +$415K |
|
1688
Celldex Therapeutics
CLDX
$1.66B
| $414K | ﹤0.01% |
+10,710
| New | +$414K |
|
|
SRNE
1689
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $414K | ﹤0.01% |
+88,990
| New | +$414K |
|
1690
AngioDynamics
ANGO
$445M
| $413K | ﹤0.01% |
14,960
-940
| -6% | -$26K |
|
1691
Genesco
GCO
$355M
| $411K | ﹤0.01% |
6,401
-12,030
| -65% | -$772K |
|
1692
Albertsons Companies
ACI
$10.4B
| $409K | ﹤0.01% |
13,538
-6,367
| -32% | -$192K |
|
1693
Array Technologies
ARRY
$1.25B
| $408K | ﹤0.01% |
+26,030
| New | +$408K |
|
|
TVTY
1694
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $407K | ﹤0.01% |
15,390
-17,210
| -53% | -$455K |
|
1695
Usana Health Sciences
USNA
$551M
| $405K | ﹤0.01% |
4,000
-7,700
| -66% | -$780K |
|
1696
The Joint Corp
JYNT
$157M
| $404K | ﹤0.01% |
6,150
-6,450
| -51% | -$424K |
|
1697
X4 Pharmaceuticals
XFOR
$76.1M
| $404K | ﹤0.01% |
5,884
+4,931
| +517% | +$339K |
|
1698
Park National Corp
PRK
$2.72B
| $401K | ﹤0.01% |
2,920
-3,180
| -52% | -$437K |
|
1699
Agios Pharmaceuticals
AGIO
$2.07B
| $400K | ﹤0.01% |
+12,180
| New | +$400K |
|
1700
DNOW Inc
DNOW
$1.61B
| $400K | ﹤0.01% |
46,857
-61,130
| -57% | -$522K |
|